Noah Medical will showcase the Galaxy System™ at the annual CHEST show

SAN CARLOS, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Innovator in medical robotics Medical Noah revealed today that the next review and evaluation of the Galaxy Physician-Only System will take place October 16-19, 2022 at the annual meeting of the American College of Chest Physicians (CHEST 2022) in Nashville, Tennessee.

The Galaxy System is a fully integrated solution for navigational robotic bronchoscopy, designed to improve localization accuracy and successful diagnosis of pulmonary nodules using its proprietary TiLT+ Technology™.

Noah medical received excellent feedback from pulmonologists and surgeons in the May technology review and evaluation at the American Thoracic Society (ATS 2022) in San Francisco and at the annual conference of the American Association of Bronchology and Interventional Pulmonology last month (AAIBP 2022). Feedback from doctors has been particularly positive regarding features of the Galaxy system such as its TiLT+ Technology™ with integrated tomosynthesis and augmented fluoroscopy, a single-use disposable bronchoscope and a reduced and compact footprint.

“I have been impressed with the design and execution decisions made so far in the Galaxy platform,” said Bobby Mahajan, MD. “Beyond the integration of tomosynthesis to improve localization and diagnosis, the shift to single-use endoscopes and a much smaller footprint all lend themselves to more efficient operation and the capacity for more clinics and systems to treat more patients The best chance of improving outcomes for our patients is to combine both robotics and imaging to increase diagnostic throughput.

“We continue to be encouraged by the physician feedback the Galaxy Platform is receiving during our first physician-only review and assessment sessions,” said Jian Zhang, PhD, Founder and CEO of Noah Medical. “Noah Medical was designed with a focus on patients and physicians to solve the most complex and difficult gaps in the early diagnosis and treatment of multiple disease states. We are thrilled to bring this innovative new navigational robotic bronchoscopy platform to market. »

Noah Medical plans to submit the Galaxy System for FDA approval later this calendar year. To schedule a physician-only demo and feedback session at CHEST 2022, please email [email protected]

To learn more about Noah Medical and the Galaxy System, visit

About Noah Medical
Noah Medical is building the future of medical robotics. Our next-generation robotic platforms and technologies target early diagnosis and treatment of patients in multiple indications. Based in Silicon Valley and backed by renowned institutional investors, our incredibly talented team of engineers, innovators and industry leaders bring years of experience from top robotics, medical device and healthcare companies. health in the world. Learn more at

Media Contact:
Stephanie Hicks
PR for Noah Medical
[email protected]